SCHEMBL6120973

SCHEMBL6120973

CCC(N)C(O)[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6242950 0.75 ANPEP (0.40)
SCHEMBL23683384 0.74
SCHEMBL11502810 0.73 TSHR (0.33)
SCHEMBL6373695 0.72
SCHEMBL10645883 0.70
SCHEMBL3734197 0.70
SCHEMBL11260080 0.69
SCHEMBL2430437 0.68
SCHEMBL27209690 0.68
SCHEMBL873184 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117466958-A Large-scale preparation of pseudotrisaccharide aminoglycosides and intermediates thereof ELOXX制药有限公司 2024-01-30 CN disclosed
US-11865128-B2 Aminoglycosides and uses thereof in treating genetic disorders TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2024-01-09 US disclosed
CN-110997689-B Aminoglycoside derivatives and their use in the treatment of genetic disorders ELOXX制药有限公司 2023-11-07 CN disclosed
CN-110637024-B Large-scale preparation of pseudotrisaccharide aminoglycosides and intermediates thereof ELOXX制药有限公司 2023-10-24 CN disclosed
US-11786539-B2 Aminoglycoside derivatives and uses thereof in treating genetic disorders ELOXX PHARMACEUTICALS LTD. (IL) 2023-10-17 US disclosed
US-20230097398-A1 AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING GENETIC DISORDERS ELOXX PHARMACEUTICALS LTD. (IL) 2023-03-30 US disclosed
US-11613551-B2 Aminoglycoside derivatives and uses thereof in treating genetic disorders ELOXX PHARMACEUTICALS LTD. (IL) 2023-03-28 US disclosed
CN-114957357-A Aminoglycoside derivatives and their use in the treatment of genetic disorders ELOXX制药有限公司 2022-08-30 CN disclosed
CN-108350014-B Aminoglycoside derivatives and their use in the treatment of genetic disorders ELOXX制药有限公司 2022-06-10 CN disclosed
US-11306115-B2 Aminoglycoside derivatives and uses thereof in treating genetic disorders ELOXX PHARMACEUTICALS LTD. (IL) 2022-04-19 US disclosed
WO-2017037718-A1 AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING GENETIC DISORDERS ELOXX PHARMACEUTICALS LTD. (IL) 2017-03-09 WO disclosed
WO-2017037719-A1 AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING GENETIC DISORDERS ELOXX PHARMACEUTICALS LTD. (IL) 2017-03-09 WO disclosed
US-20160074425-A1 AMINOGLYCOSIDES AND USES THEREOF IN TREATING GENETIC DISORDERS TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2016-03-17 US disclosed
WO-2015186134-A1 USE OF AMINOGLYCOSIDE ANALOGS IN THE TREATMENT OF RETT SYNDROME ELOXX PHARMACEUTICALS LTD. (IL) 2015-12-10 WO disclosed
US-9175029-B2 Aminoglycosides and uses thereof in treating genetic disorders TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2015-11-03 US disclosed
US-20140357590-A1 AMINOGLYCOSIDES AND USES THEREOF IN TREATING GENETIC DISORDERS TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2014-12-04 US disclosed
US-8895519-B2 Aminoglycosides and uses thereof in treating genetic disorders TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2014-11-25 US disclosed
EP-2640734-A1 AMINOGLYCOSIDES AND USES THEREOF IN TREATING GENETIC DISORDERS Technion Research & Development Foundation Ltd. (IL) 2013-09-25 EP disclosed
US-20130237489-A1 AMINOGLYCOSIDES AND USES THEREOF IN TREATING GENETIC DISORDERS TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2013-09-12 US disclosed
WO-2012066546-A1 AMINOGLYCOSIDES AND USES THEREOF IN TREATING GENETIC DISORDERS TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) 2012-05-24 WO disclosed